TYRP1 and melanoma: TYRP1 was highly overexpressed (log2 FPKM ≥ 7) in ~30% of melanomas overall and up to ~90% in uveal melanoma, including in biopsies from patients resistant to immune checkpoint inhibitors, supporting its clinical relevance.